Effect of slow abdominal breathing combined with biofeedback on blood pressure and heart rate variability in prehypertension

Journal of Alternative and Complementary Medicine

Volumn 16, Issue 10, 2010, Pages 1039-1045

  Wang, Shu Zhen ^a   Li, Sha ^a   Xu, Xiao Yang ^a,b   Lin, Gui Ping ^a   Shao, Li ^a   Zhao, Yan ^a   Wang, Ting Huai ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL BREATHING; ADULT; ARTICLE; BLOOD PRESSURE; BREATHING EXERCISE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROMYOGRAPHY; FEEDBACK SYSTEM; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; POSTMENOPAUSE; PREHYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VAGUS TONE;

BIOFEEDBACK, PSYCHOLOGY; BLOOD PRESSURE; BREATHING EXERCISES; COMBINED MODALITY THERAPY; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREHYPERTENSION; RESPIRATION;

EID: 77958171207     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0577     Document Type: Article

References (36)

1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;19:2560-2572.
2. Kokubo Y, Kamide K. High-normal blood pressure and the risk of cardiovascular disease. Circ J 2009;8:1381-1385.
3. Kshirsagar AV, Carpenter M, Bang H, et al. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006;2:133-141.
4. Manios E, Tsivgoulis G, Koroboki E, et al. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass. Stroke 2009;4:1515-1518.
5. Egan BM, Julius S. Prehypertension: Risk stratification and management considerations. Curr Hypertens Rep 2008;5:359-366.
6. Faye K, Heng LH, Collomp R, Peroux E. Hypertension and stress. J Mal Vasc 2003;1:4-8.
7. Luders S, Hammersen F, Kulschewski A, et al. Stressassociated hypertension in the work place: Results of the STARLET project. Dtsch Med Wochenschr 2006;46:2580-2585.
8. Tennant C. Life stress and hypertension. J Cardiovasc Risk 2001;1:51-56.
9. Schwickert M, Langhorst J, Paul A, et al. Stress management in the treatment of essential arterial hypertension. MMW Fortschr Med 2006;47:40-42; quiz 43.
10. Mourya M, Mahajan AS, Singh NP, Jain AK. Effect of slowand fast-breathing exercises on autonomic functions in patients with essential hypertension. J Altern Complement Med 2009;7:711-717.
11. Pinheiro CH, Medeiros RA, Pinheiro DG, Marinho Mde J. Spontaneous respiratory modulation improves cardiovascular control in essential hypertension. Arq Bras Cardiol 2007;6:651-659.
12. Rosenthal T, Alter A, Peleg E, Gavish B. Device-guided breathing exercises reduce blood pressure: Ambulatory and home measurements. Am J Hypertens 2001;1:74-76.
13. Altena MR, Kleefstra N, Logtenberg SJ, et al. Effect of device-guided breathing exercises on blood pressure in patients with hypertension. Blood Press 2009 Sep. 10:1-7. [Epub ahead of print]
14. Nakao M, Yano E, Nomura S, Kuboki T. Blood pressurelowering effects of biofeedback treatment in hypertension: A meta-analysis of randomized controlled trials. Hypertens Res 2003;1:37-46.
15. Yucha CB, Clark L, Smith M, et al. The effect of biofeedback in hypertension. Appl Nurs Res 2001;1:29-35.
16. Yucha CB, Tsai PS, Calderon KS, Tian L. Biofeedbackassisted relaxation training for essential hypertension: Who is most likely to benefit? J Cardiovasc Nurs 2005;3:198-205.
17. Linden W, Moseley JV. The efficacy of behavioral treatments for hypertension. Appl Psychophysiol Biofeedback 2006;1:51-63.
18. Yucha CB. Problems inherent in assessing biofeedback efficacy studies. Appl Psychophysiol Biofeedback 2002;1:99-106.
19. Kaushik R, Kaushik RM, Mahajan SK, Rajesh V. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine. Complement Ther Med 2005;3:165-174.
20. Camm AJ, Malik M, Bigger JT, et al. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;5:1043-1065.
21. Xu XY, Gao J, Ling D, Wang TH. Biofeedback treatment of prehypertension: Analyses of efficacy, heart rate variability and EEG approximate entropy. J Hum Hypertens 2007;12:973-975.
22. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001;9294:1682-1686.
23. Moravec CS. Biofeedback therapy in cardiovascular disease: Rationale and research overview. Cleve Clin J Med 2008;75(suppl 2): S35-S38.
24. McGrady A. Good news-bad press: Applied psychophysiology in cardiovascular disorders. Biofeedback Self Regul 1996;4:335-346.
25. Nakao M, Nomura S, Shimosawa T, et al. Blood pressure biofeedback treatment of white-coat hypertension. J Psychosom Res 2000;2:161-169.
26. Joseph CN, Porta C, Casucci G, et al. Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension 2005;4:714-718.
27. Bernardi L, Gabutti A, Porta C, Spicuzza L. Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J Hypertens 2001;12:2221-2229.
28. Bernardi L, Porta C, Spicuzza L, et al. Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation 2002;2:143-145.
29. Montano N, Cogliati C, Porta A, et al. Central vagotonic effects of atropine modulate spectral oscillations of sympathetic nerve activity. Circulation 1998;14:1394-1399.
30. Naughton MT, Floras JS, Rahman MA, et al. Respiratory correlates of muscle sympathetic nerve activity in heart failure. Clin Sci (Lond) 1998;3:277-285.
31. Del Pozo JM, Gevirtz RN, Scher B, Guarneri E. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J 2004;3: E11.
32. de Champlain J, Cousineau D, Lapointe L. Evidences supporting an increased sympathetic tone and reactivity in a subgroup of patients with essential hypertension. Clin Exp Hypertens 1980;3-4:359-377.
33. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006;5:335-346.
34. Morise T, Horita M, Kitagawa I, et al. The potent role of increased sympathetic tone in pathogenesis of essential hypertension with neurovascular compression. J Hum Hypertens 2000;12:807-811.
35. Cowan MJ, Kogan H, Burr R, et al. Power spectral analysis of heart rate variability after biofeedback training. J Electrocardiol 1990; Suppl 1:85-94.
36. Nolan RP, Kamath MV, Floras JS, et al. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J 2005;6:1137.